Pulmonary Cell News Volume 11.23 | Jun 16 2022

    0
    20







    2022-06-16 | PULCN 11.23


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 11.23 – 16 June, 2022
    TOP STORY

    Airway Prevotella Promote TLR2-Dependent Neutrophil Activation and Rapid Clearance of Streptococcus pneumoniae from the Lung

    Scientists showed that Prevotella melaninogenica enhanced protection against Streptococcus pneumoniae, resulting in rapid pathogen clearance from the lung and improved survival in a mouse lung co-infection model.
    [Nature Communications]

    Full Article
    Free Wallchart: Dynamic Modeling in Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

    Cell compatibility, uptake, and intracellular trafficking were characterized in the murine alveolar macrophage cell line MH-S and the human bronchial epithelial cell line BEAS-2B in vitro.
    [Small]

    Full Article

    STAT6 Inhibits Ferroptosis and Alleviates Acute Lung Injury via Regulating P53/SLC7A11 Pathway

    Investigators identified that signal transducer and activators of transduction 6 (STAT6) acted as a critical regulator of epithelium ferroptosis during acute lung injury.
    [Cell Death & Disease]

    Full Article

    Minilungs from Human Embryonic Stem Cells to Study the Interaction of Streptococcus pneumoniae with the Respiratory Tract

    Researchers generated lung bud organoids derived from human embryonic stem cells to study the interaction of Streptococcus pneumoniae with the alveolar epithelium.
    [Microbiology Spectrum]

    Full Article

    Metabolic and Epigenetic Regulation of SMAD7 by Stanniocalcin-1 (STC1) Ameliorates Lung Fibrosis

    To examine the overall effect of STC1 on metabolism, scientists conducted a comprehensive metabolomics analysis to screen the overall metabolic changes induced by STC1 in an alveolar epithelial cell line.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    Intermediary Role of Lung Alveolar Type 1 Cells in Epithelial Repair Upon Sendai Virus Infection

    Using Sendai virus to model natural infection in mice, investigators found evidence that alveolar type 1 cells had an intermediary role by persisting in areas depleted of alveolar type 2 cells, upregulating interferon responsive genes, and receding from invading airway cells.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    Ethanol Extract of Veronica persica Ameliorates House Dust Mite-Induced Asthmatic Inflammation by Inhibiting STAT-3 and STAT-6 Activation

    Researchers evaluated the pharmacological activity of the ethanol extract of Veronica persica in an airway inflammation model.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    Interleukin-6 Neutralizing Antibody Attenuates the Hypersecretion of Airway Mucus via Inducing the Nuclear Translocation of Nrf2 in Chronic Obstructive Pulmonary Disease

    The authors investigated the mechanisms underlying the action of interleukin-6 neutralizing antibodies in attenuating airway mucus hypersecretion in COPD.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    Post-Translational Modifications to Hemidesmosomes in Human Airway Epithelial Cells Following Diacetyl Exposure

    Investigators assessed for changes in abundance and distribution of hemidesmosome-associated proteins following diacetyl (DA) exposure that contributed to DA-induced epithelial toxicity.
    [Scientific Reports]

    Full Article

    Syntaxin 18 Regulates the DNA Damage Response and Epithelial-to-Mesenchymal Transition To Promote Radiation Resistance of Lung Cancer

    In an unbiased functional genetic screen for radiosensitization targets in lung cancer, scientists identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance.
    [Cell Death & Disease]

    Full Article

    AGE/RAGE Axis Regulates Reversible Transition to Quiescent States of ALK-Rearranged NSCLC and Pancreatic Cancer Cells in Monolayer Cultures

    Researchers reported monolayer cancer cell models wherein the human NSCLC cell line H2228 and pancreatic cancer cell line AsPC-1 could be reversibly induced to a quiescent state under hypoxic and serum-starved conditions.
    [Scientific Reports]

    Full Article

    Integrative Metabolomics and Transcriptomics Analysis Reveals Novel Therapeutic Vulnerabilities in Lung Cancer

    Scientists identified unique metabolite-related gene signatures specific for lung adenocarcinoma and lung squamous cell carcinoma and key pathways aberrantly regulated at both transcriptional and metabolic levels.
    [Cancer Medicine]

    Full Article

    Semaphorin 4B Promotes Tumor Progression and Associates With Immune Infiltrates in Lung Adenocarcinoma

    The functions of semaphorin 4B in lung adenocarcinoma cells were investigated by in vitro experiments, including CCK-8 and plate clone formation.
    [BMC Cancer]

    Full Article
    The Immunology Podcast is here. Find it wherever you get your podcasts.
    REVIEWS

    From COVID to Fibrosis: Lessons From Single-Cell Analyses of the Human Lung

    Investigators discuss changes in cell populations and gene expression, highlighting potential common features, such as alveolar cell epithelial injury and aberrant repair and monocyte-derived macrophage populations.
    [Human Genomics]

    Full Article
    INDUSTRY AND POLICY NEWS

    Galecto Announces First Patient Enrolled in Phase II Trial of GB1211 in Combination with Atezolizumab for First-Line Treatment of NSCLC

    Galecto, Inc. announced that the first patient has been enrolled in the Phase IIa GALLANT-1 trial. GALLANT-1 was designed to study the combination of GB1211, Galecto’s oral small molecule galectin-3 inhibitor, with Roche’s PD-L1 checkpoint inhibitor, atezolizumab, for the first-line treatment of NSCLC.
    [Galecto, Inc.]

    Press Release
    FEATURED EVENT

    Advances in Therapeutic Applications of Stem Cells

    December 8 – 10, 2022
    Los Angeles, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Interorgan Crosstalk

    Washington University School of Medicine – St. Louis, Missouri, United States

    Academic Surgical Pathologist – Pathology and Laboratory Medicine

    University of Vermont – Burlington, Vermont, United States

    Postdoctoral Associate – Lung and Liver Injury in Sickle Cell Disease

    University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States

    Tenure Track Assistant or Associate Professor – Lung Inflammation

    Temple University – Philadelphia, Pennsylvania, United States

    Postdoctoral Candidate – Cancer Biology

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter